Skip to ContentSkip to Navigation
About us Latest news News News articles

Community-acquired pneumonia. Monitoring and modulation of the host response

03 October 2012

PhD ceremony: Mr. D. Snijders, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Community-acquired pneumonia. Monitoring and modulation of the host response

Promotor(s): prof. T.S. van der Werf

Faculty: Medical Sciences

This thesis reports several studies investigating the host response induced by a community-acquired pneumonia. The host response consists of several aspects, including a general inflammatory response and activation of the anticoagulation system. Changes in various haematologic parameters are also observed. This response can elicit an exaggerated inflammation which supersedes the amount of response needed for dealing with the offending pathogens and can cause excess damage. In this thesis the hypothesis is tested whether adjunctive corticosteroids, anti-inflammatory agents, are beneficial in patients with a community-acquired pneumonia. In a randomised clinical trial involving 213 patients, adjunctive corticosteroids did not lead to improved clinical outcome. The use of corticosteroids was associated with an increase in late failure, which required additional treatment. Furthermore, the use of D-dimers, fibrin-degradation products, as marker for community-acquired pneumonia are investigated. D-dimers as standalone markers, or combined with the CURB-65 score, did not improve the severity scoring in patients with community-acquired pneumonia. The haematological changes due to community-acquired pneumonia are caused by a diminished incorporation of iron in red blood cells. This effect is likely caused by hepcidin, a regulatory protein. The findings of this thesis provide insight in the host response occurring in community-acquired pneumonia, and points out issues for further research of the host response and treatment of community-acquired pneumonia.

Last modified:13 March 2020 01.01 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.